Literature DB >> 3899812

Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects.

O Schmitz.   

Abstract

A three-step euglycemic insulin clamp was performed in six matched groups: nine healthy subjects, 10 insulin-dependent diabetic (IDD) subjects with normal kidney function, 10 nondiabetic uremic subjects, six nondialyzed uremic IDD subjects, seven uremic IDD subjects on chronic hemodialysis (HD), and six uremic IDD subjects on chronic ambulatory peritoneal dialysis (CAPD). Insulin was infused sequentially at rates of 0.5 (step 1), 2.0 (step 2), and 4.0 (step 3) mU X kg-1 X min-1. Each dose was given for 120 min; however, in the IDD subjects with fasting hyperglycemia, step 1 of the clamp was slightly extended. Average serum free insulin levels at steady state ranged from 22 to 342 microU/ml and were comparable in all groups. Step 3 glucose infusion rate (GIR), the last 30 min of the infusion period, was extremely suppressed in nondialyzed uremic IDD subjects, amounting to 53% of that in healthy subjects (7.7 +/- 0.7 versus 14.4 +/- 0.9 mg X kg-1 X min-1, P less than 0.001) indicating severe insulin resistance in peripheral tissues. As expected, step 3 glucose disposal was also reduced in IDD subjects with normal kidney function (12.4 +/- 0.6 mg X kg-1 X min-1) and nondiabetic uremic subjects (9.2 +/- 0.6 mg X kg-1 X min-1) as compared with healthy subjects (P = 0.06 and P less than 0.001, respectively). The pronounced impairment of insulin responsiveness in nondialyzed uremic IDD subjects was almost equal to the sum of the defects in nondiabetic uremic and IDD subjects with normal kidney function.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899812     DOI: 10.2337/diab.34.11.1152

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.

Authors:  Georg Biesenbach; Gert Bodlaj; Stephan Ebner; Peter Biesenbach; Herwig Pieringer
Journal:  Int Urol Nephrol       Date:  2010-07-20       Impact factor: 2.370

Review 2.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

Review 3.  Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.

Authors:  Jongha Park; Paungpaga Lertdumrongluk; Miklos Z Molnar; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 4.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

5.  Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.

Authors:  Eugene Sobngwi; Sostanie Enoru; Gloria Ashuntantang; Marcel Azabji-Kenfack; Mesmin Dehayem; Arnold Onana; Daniel Biwole; François Kaze; Jean-François Gautier; Jean-Claude Mbanya
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 17.152

6.  Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.

Authors:  Kamyar Kalantar-Zadeh; Stephen F Derose; Susan Nicholas; Deborah Benner; Kumar Sharma; Csaba P Kovesdy
Journal:  J Ren Nutr       Date:  2009-01       Impact factor: 3.655

7.  Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients.

Authors:  Hassan Argani; Alireza Noorazarian; Mohammad Rahbaninobar; Mohammad Noori; Hamid T Khosroshahi
Journal:  BMC Nephrol       Date:  2004-09-08       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.